JP Morgan Maintains Underweight on QuidelOrtho, Raises Price Target to $12
JP Morgan analyst Casey Woodring maintains QuidelOrtho (NASDAQ: QDEL ) with a Underweight and raises the price target from $11 to $12.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.